Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD

References

• World Health Organization. The Global Burden of Disease: 2004 Update. World Health Organization; 2008.
   Google Scholar
• von Leupoldt A, Fritzsche A, Trueba AF, Meuret AE, Ritz T. Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med. 2012;44(1):52–65. doi:10.1007/s12160-012-9348-7
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4Suppl):43S–56S. doi:10.1378/chest.08-0342
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349. doi:10.1183/09059180.00007813
   PubMedGoogle Scholar
• Ulrik CS, Vijverberg S, Hanania NA, Diamant Z. Precision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020;26(1):33–39. doi:10.1097/MCP.0000000000000639
   PubMed Web of Science ®Google Scholar
• Young AL, Bragman FJS, Rangelov B, et al. Disease progression modeling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020;201(3):294–302. doi:10.1164/rccm.201908-1600OC
   PubMed Web of Science ®Google Scholar
• Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217–223. doi:10.1016/j.genhosppsych.2011.03.009
   PubMed Web of Science ®Google Scholar
• Matte DL, Pizzichini MM, Hoepers AT, et al. Prevalence of depression in COPD: a systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154–161. doi:10.1016/j.rmed.2016.06.006
   PubMed Web of Science ®Google Scholar
• Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int J Epidemiol. 2014;43(2):476–493. doi:10.1093/ije/dyu038
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA. 2004;291(21):2581–2590. doi:10.1001/jama.291.21.2581
   PubMed Web of Science ®Google Scholar
• Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010;137(2):341–347. doi:10.1378/chest.09-0614
   PubMed Web of Science ®Google Scholar
• van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688–692. doi:10.1136/thx.54.8.688
   PubMed Web of Science ®Google Scholar
• Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.0037483
   PubMed Web of Science ®Google Scholar
• Iyer AS, Holm KE, Bhatt SP, et al. Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - a cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019;118:18–26. doi:10.1016/j.jpsychores.2019.01.002
   PubMed Web of Science ®Google Scholar
• Hilmarsen CW, Wilke S, Engan H, et al. Impact of symptoms of anxiety and depression on COPD assessment test scores. Eur Respir J. 2014;43(3):898–900. doi:10.1183/09031936.00163913
   PubMed Web of Science ®Google Scholar
• Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest. 2002;122(5):1633–1637. doi:10.1378/chest.122.5.1633
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2003;18(5):412–416. doi:10.1002/gps.851
   PubMed Web of Science ®Google Scholar
• Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23(2):56–61. doi:10.1016/s0163-8343(01)00127-x
   PubMed Web of Science ®Google Scholar
• Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65–70. doi:10.1080/08039480310000824
   PubMed Web of Science ®Google Scholar
• Moermans C, Heinen V, Nguyen M, et al. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine. 2011;56(2):298–304. doi:10.1016/j.cyto.2011.07.010
   PubMed Web of Science ®Google Scholar
• Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res. 2011;12:3. doi:10.1186/1465-9921-12-3
   PubMed Web of Science ®Google Scholar
• Chen Y-WR, Leung JM, Sin DD, Eickelberg O. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One. 2016;11(7):e0158843. doi:10.1371/journal.pone.0158843
   PubMed Web of Science ®Google Scholar
• Wei J, Xiong XF, Lin YH, Zheng BX, Cheng DY. Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ. 2015;3:e1199. doi:10.7717/peerj.1199
   PubMed Web of Science ®Google Scholar
• Lu Y, Feng L, Nyunt MS, Yap KB, Ng TP. Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Respir Res. 2013;14:53. doi:10.1186/1465-9921-14-53
   PubMed Web of Science ®Google Scholar
• Chang SS, Vaz Fragoso CA, Van Ness PH, Fried LP, Tinetti ME. Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the women’s health and aging studies I and II. J Am Geriatr Soc. 2011;59(1):113–119. doi:10.1111/j.1532-5415.2010.03203.x
   PubMed Web of Science ®Google Scholar
• Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination. Am J Med. 2003;114(9):758–762. doi:10.1016/S0002-9343(03)00185-2
   PubMed Web of Science ®Google Scholar
• de Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27(5):902–907. doi:10.1183/09031936.06.00109605
   PubMed Web of Science ®Google Scholar
• Janssen DJ, Mullerova H, Agusti A, et al. Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med. 2014;108(11):1647–1654. doi:10.1016/j.rmed.2014.07.013
   PubMed Web of Science ®Google Scholar
• Hodes GE, Ménard C, Russo SJ. Integrating interleukin-6 into depression diagnosis and treatment. Neurobiol Stress. 2016;4:15–22. doi:10.1016/j.ynstr.2016.03.003
   PubMed Web of Science ®Google Scholar
• Ting EY, Yang AC, Tsai SJ. Role of interleukin-6 in depressive disorder. Int J Mol Sci. 2020;21(6):2194. doi:10.3390/ijms21062194
   PubMed Web of Science ®Google Scholar
• Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736–744. doi:10.1016/j.jad.2013.06.004
   PubMed Web of Science ®Google Scholar
• Allison DJ, Ditor DS. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation. 2014;11(1):151. doi:10.1186/s12974-014-0151-1
   PubMedGoogle Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34. doi:10.1038/nri.2015.5
   PubMed Web of Science ®Google Scholar
• Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967;113(504):1237–1264. doi:10.1192/bjp.113.504.1237
   PubMed Web of Science ®Google Scholar
• Zalli A, Jovanova O, Hoogendijk WJ, Tiemeier H, Carvalho LA. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology. 2016;233(9):1669–1678. doi:10.1007/s00213-015-3919-9
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–186. doi:10.1097/PSY.0b013e3181907c1b
   PubMed Web of Science ®Google Scholar
• Hanania NA, Müllerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604–611. doi:10.1164/rccm.201003-0472OC
   PubMed Web of Science ®Google Scholar
• Bon J, Fuhrman CR, Weissfeld JL, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med. 2011;183(7):885–890. doi:10.1164/rccm.201004-0666OC
   PubMed Web of Science ®Google Scholar
• Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43. doi:10.3109/15412550903499522
   PubMedGoogle Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology. 2017;22(3):575–601. doi:10.1111/resp.13012
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi:10.1001/archpsyc.1961.01710120031004
   PubMed Web of Science ®Google Scholar
• Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002;43(5):386–393. doi:10.1176/appi.psy.43.5.386
   PubMed Web of Science ®Google Scholar
• Reeves GM, Rohan KJ, Langenberg P, Snitker S, Postolache TT. Calibration of response and remission cut-points on the beck depression inventory-second edition for monitoring seasonal affective disorder treatment outcomes. J Affect Disord. 2012;138(1–2):123–127. doi:10.1016/j.jad.2011.12.003
   PubMed Web of Science ®Google Scholar
• Wang YP, Gorenstein C. Psychometric properties of the beck depression inventory-II: a comprehensive review. Braz J Psychiatry. 2013;35(4):416–431. doi:10.1590/1516-4446-2012-1048
   PubMed Web of Science ®Google Scholar
• Bock K, Bendstrup E, Hilberg O, Lokke A. Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review. Eur Clin Respir J. 2017;4(1):1332931. doi:10.1080/20018525.2017.1332931
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Dowson C, Laing R, Barraclough R, et al. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J. 2001;114(1141):447–449.
   PubMed Web of Science ®Google Scholar
• Carolan BJ, Hughes G, Morrow J, et al. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res. 2014;15(1):127. doi:10.1186/s12931-014-0127-9
   PubMed Web of Science ®Google Scholar
• Sun W, Kechris K, Jacobson S, et al. Common genetic polymorphisms influence blood biomarker measurements in COPD. PLoS Genet. 2016;12(8):e1006011. doi:10.1371/journal.pgen.1006011
   PubMed Web of Science ®Google Scholar
• Tsai TY, Livneh H, Lu MC, Tsai PY, Chen PC, Sung FC. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health. 2013;13:976. doi:10.1186/1471-2458-13-976
   PubMed Web of Science ®Google Scholar
• Réus GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies. J Psychiatr Res. 2015;68:316–328. doi:10.1016/j.jpsychires.2015.05.007
   PubMed Web of Science ®Google Scholar